Austar Lifesciences Limited (HKG:6118)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7300
-0.0500 (-6.41%)
At close: Mar 4, 2026
Market Cap374.18M +23.7%
Revenue (ttm)1.60B -5.4%
Net Income38.57M
EPS0.08
Shares Out512.58M
PE Ratio9.70
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume34,000
Average Volume176,750
Open0.7500
Previous Close0.7800
Day's Range0.7300 - 0.7500
52-Week Range0.6500 - 1.9700
Beta1.25
RSI32.58
Earnings DateMar 27, 2026

About Austar Lifesciences

Austar Lifesciences Limited, an investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. The company operates through Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC) segments. It also offers clean utility and bioprocess equipment, clean room, automation control and monitor system; bioprocess equipment consumab... [Read more]

Sector Healthcare
Founded 1991
Employees 1,446
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6118
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements